Two mRNA vaccines, which received emergency authorization in late 2020, have proven critical in the fight against COVID-19. These vaccines, the first of their kind, were the culmination of decades of research on RNA. Delivered ...
May 16, 2022
0
20
Peter Palese pulls open the door of a 16th floor lab room at Mount Sinai's upper east side hospital.
May 9, 2022
0
6
Two experimental vaccines show promise in protecting against infection with the "mono" virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports.
May 8, 2022
0
28
Rutgers researchers made a startling discovery when the pandemic curtailed routine medical visits: Going virtual to test cutting-edge therapies reached more diverse patients.
May 6, 2022
0
16
A team of researchers from the French health care company Sanofi, working with the National Institutes of Health and the National Cancer Institute in the U.S., has developed two new vaccines against Epstein-Barr infections. ...
The first three coronavirus vaccines earned Emergency Use Authorization more than a year ago. To date, no other vaccines have been put into use in the U.S—but that will soon change. More than 40 vaccines are undergoing ...
May 5, 2022
0
119
A new study from the University of Illinois Chicago examines key themes and topics from almost three million COVID-19 vaccine-related tweets posted by individuals and explores the trends and variations in public opinions ...
Apr 27, 2022
1
19
Researchers with Cincinnati Children's Hospital Medical Center conducted a randomized clinical trial to determine the effectiveness of outreach reminders on adolescent well child visits and COVID-19 vaccination rates. Findings ...
Apr 22, 2022
0
10
In most methods used today, clinical trials designed to evaluate the safety of a new drug or vaccine employ self-report questionnaires, asking participants how they feel before and after receiving the treatment. A new study ...
Apr 13, 2022
0
39
Some of Rutgers' top health researchers are calling for a change in our approach to developing COVID-19 vaccines, and vaccines to fight future pandemics, to incorporate both conventional and challenge trails. Conventional ...
Apr 12, 2022
0
18
